Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 44 results

research Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy

26 citations , October 2019 in “JNCI Cancer Spectrum”

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Testosterone Levels in Relation to Oral Contraceptive Use and the Androgen Receptor CAG and GGC Length Polymorphisms in Healthy Young Women

research Testosterone Levels in Relation to Oral Contraceptive Use and the Androgen Receptor CAG and GGC Length Polymorphisms in Healthy Young Women

25 citations , August 2006 in “Human Reproduction”

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

research Relationships, Intimacy, and Body Image After Breast Cancer

September 2016 in “Oncology times”

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

research Hormone Replacement Therapy for Women with Premature Ovarian Insufficiency: A Comprehensive Review

61 citations , January 2017 in “Human Reproduction Open”

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

research Case Study: Hereditary Cancer Genetic Testing in Unaffected Patients May Allow for Early Intervention and Aggressive Management

October 2014 in “Journal of Minimally Invasive Gynecology”

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

View more "brca mutation" in research →

Community Join

1 / 1 results

community One and a half year on meds (fin/dut, minox)

in Progress Pictures 54 upvotes 10 months ago

The user has been using oral minoxidil, finasteride, and dutasteride to prevent hair loss, despite not showing significant balding. Many commenters believe the treatment is excessive, while some support early prevention.